医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2014年
15期
32-33
,共2页
中西医结合%重症肌无力%临床观察
中西醫結閤%重癥肌無力%臨床觀察
중서의결합%중증기무력%림상관찰
目的:探讨中西医结合治疗重症肌无力的临床疗效。方法将39例重症肌无力患者分为A组(单纯西医治疗组) B组(单纯中医治疗组) C组(中西医结合治疗组)三组。对验结果进行分析,研究三组的治愈率。结果西药组痊愈率为15.39%(2/13),显效率为15.39%(2/13),总治愈率为30.78%;中药组痊愈率为7.69%(2/13),显效率为15.39%(2/13),总治愈率为23.08%;中西医结合治疗组痊愈率为23.08%(3/13),显效率为30.77%(4/13),总治愈率为53.85%。结论中西医结合治疗重症肌无力临床效果更为满意,值得在临床上推广。
目的:探討中西醫結閤治療重癥肌無力的臨床療效。方法將39例重癥肌無力患者分為A組(單純西醫治療組) B組(單純中醫治療組) C組(中西醫結閤治療組)三組。對驗結果進行分析,研究三組的治愈率。結果西藥組痊愈率為15.39%(2/13),顯效率為15.39%(2/13),總治愈率為30.78%;中藥組痊愈率為7.69%(2/13),顯效率為15.39%(2/13),總治愈率為23.08%;中西醫結閤治療組痊愈率為23.08%(3/13),顯效率為30.77%(4/13),總治愈率為53.85%。結論中西醫結閤治療重癥肌無力臨床效果更為滿意,值得在臨床上推廣。
목적:탐토중서의결합치료중증기무력적림상료효。방법장39례중증기무력환자분위A조(단순서의치료조) B조(단순중의치료조) C조(중서의결합치료조)삼조。대험결과진행분석,연구삼조적치유솔。결과서약조전유솔위15.39%(2/13),현효솔위15.39%(2/13),총치유솔위30.78%;중약조전유솔위7.69%(2/13),현효솔위15.39%(2/13),총치유솔위23.08%;중서의결합치료조전유솔위23.08%(3/13),현효솔위30.77%(4/13),총치유솔위53.85%。결론중서의결합치료중증기무력림상효과경위만의,치득재림상상추엄。
Objective To investigate the clinical effect of combined traditional Chinese and Western medicine treatment of myasthenia gravis. Methods 39 cases of myasthenia gravis patients were divided into three groups: A group (Western medicine treatment group), B group ( pure Chinese medicine treatment group) and C group (treated with combination of TCM and Western Medicine). The cure rate of three groups were analyzed from the test results,. Results In the western medicine group, the cure rate was 15.39% (2/13), the effective rate was 15.39% (2/13), the total effective rate was 30.78%. In the traditional Chinese medicine group, the cure rate was 7.69% (2/13), the effective rate was 15.39% (2/13), the total effective rate was 23.08%.The cure rate of the treatment group with a combination of Chinese and Western Medicine was 23.08% (3/13), significant efficiency 30.77% (4/13), the total effective rate was 53.85%. Conclusion The combination of traditional Chinese and Western medicine treatment of the clinical effect of myasthenia gravis is more satisfactory, and it is worth promoting in clinical practice.